文献速递烧伤创面修复

血清锌正常化对严重烧伤患者临床结局的影响

The impact of serum zinc normalization on clinical outcomes in severe burn patients.
PubMed 文献 · Burns · 2019-09-21

本回顾性单中心研究纳入56例烧伤面积≥10%TBSA且至少三次血清锌检测的患者,比较血清锌正常(≥60 mcg/mL)与非正常(<60 mcg/mL)组的临床结局。结果发现两组住院时间/TBSA指数无显著差异,正常组90%上皮化时间缩短但在调整TBSA和移植次数后不显著,感染和高血糖发生率无差异。结论提示个体化补锌使血清锌正常化未改善住院期间临床结局,可考虑固定剂量补锌而不必检测血清锌。

要点

  • 血清锌正常化与住院时间/TBSA指数无关(1.10 vs 1.21,p=0.69)。
  • 正常组90%上皮化时间缩短(27.5 vs 57天,p=0.02),调整后不显著(p=0.18)。
  • 感染和高血糖发生率两组无显著差异。

核心结论

  • 个体化补锌使血清锌正常化未改善严重烧伤患者住院期间临床结局,可考虑固定剂量补锌而不检测血清锌。

研究设计与样本

  • 回顾性单中心研究,纳入至少10%TBSA烧伤且三次血清锌检测的56例患者(正常11例,非正常45例)。

主要发现

  • 住院时间/TBSA指数正常组1.10 vs 非正常组1.21,未调整p=0.69,调整移植次数后p=0.75。
  • 90%上皮化时间正常组27.5天 vs 非正常组57天,p=0.02,调整TBSA和移植次数后p=0.18。
  • 感染发生率和血糖>180 mg/dL比例两组未调整和调整分析均无显著差异。

关键数值与推荐

  • 血清锌正常定义为≥60 mcg/mL,非正常为<60 mcg/mL,依据第三次测量划分。
  • 烧伤面积正常组中位数20.5%TBSA[11-29],非正常组27.3%[22-36];移植次数分别为1[0-1]和2[1-3]。

临床怎么用

  • 严重烧伤患者可考虑固定剂量补锌,而不必常规检测血清锌以指导个体化补锌。

局限性

  • 回顾性单中心设计,样本量小(56例),正常组仅11例,可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with thermal burns become zinc deficient due to exudative losses, increased urinary excretion, and reduction of carrier proteins which results in impaired immunity, wound healing and glucose control. Previous trials have demonstrated improved wound healing utilizing fixed zinc supplementation, but none have assessed the potential benefits associated with normalizing serum zinc concentrations. The objective of this study was to compare the impact of zinc normalization on clinical outcomes in patients with severe thermal burns. METHODS: This retrospective, single-center study of patients with at least 10% total body surface area (TBSA) burn and three serum zinc concentrations compared the ratio of hospital length of stay (LOS) over TBSA burned (LOS/TBSA index) between those with normal (≥60 mcg/mL) and non-normal (<60 mcg/mL) serum zinc concentrations; delineated by the third measurement. Secondary outcomes were time to 90% epithelialization, infection incidence, and percentage of blood glucose values greater than 180 mg/dL. Data are reported as median [25-75% interquartile range] for continuous variables and frequency (percent) for categorical variables. RESULTS: A total of 56 patients were included for evaluation (11 normal and 45 non-normal). Burn size was 20.5% TBSA [11-29] for those with normal zinc and 27.3% [22-36] for non-normal; number of grafts for each group was 1 [0-1] vs 2 [1-3] respectively. LOS/TBSA index did not differ significantly between groups (1.10 normal vs. 1.21 non-normal, unadjusted p = 0.69; p = 0.75 adjusting for number of grafts). Time to 90% epithelialization was reduced in the normal group (27.5 vs. 57 days, p = 0.02), but this did not remain statistically significant after adjustment for %TBSA and number of grafts (p = 0.18). The groups did not differ significantly in incidence of infection or hyperglycemia in either unadjusted or adjusted analyses. CONCLUSIONS: This was the first study, to our knowledge, to assess the clinical impact of normalizing serum zinc levels in patients with severe burns. Our results suggest the normalization of serum zinc levels through individualized zinc supplementation is not associated with improvement in clinical outcomes during hospitalization and therefore fixed-dose zinc supplementation without acquisition of serum zinc measurements should be considered.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Olson LM, Coffey R, Porter K, et al. The impact of serum zinc normalization on clinical outcomes in severe burn patients. Burns. 2019. PMID: 31551184. doi:10.1016/j.burns.2019.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。